Page last updated: 2024-12-08

tyvelose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tyvelose: see also records for paratose & colitose; RN given refers to (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12303782
SCHEMBL ID22748767
MeSH IDM0054469

Synonyms (19)

Synonym
tyv ,
tyvelose
AKOS006329012
d-tyvelose
3,6-dideoxy-d-arabinopyranose
3,6-dideoxy-arabinopyranose
3,6-dideoxy-arabino-hexopyranose
3,6-dideoxy-d-arabinose
3,6-dideoxy-arabinopyranoside
3,6-dideoxy-arabinose
3,6-dideoxy-d-arabinopyranoside
3,6-dideoxy-d-arabino-hexopyranose
d-tyv
W-200598
C21062
3,6-dideoxy-d-mannopyranose
554-04-1
DTXSID501296895
SCHEMBL22748767
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (13.85)18.7374
1990's18 (27.69)18.2507
2000's29 (44.62)29.6817
2010's8 (12.31)24.3611
2020's1 (1.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (6.15%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (93.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]